2 years ago
OpenEvidence Aims to Keep Doctors Up-to-Date with AI-Powered Medical Information Retrieval
OpenEvidence, a health AI startup valued at $425 million, is tackling the challenge of keeping large language models up-to-date with the latest scientific research
Founded by Daniel Nadler, who previously sold his AI startup Kensho Technologies to S&P Global for $550 million, OpenEvidence aims to provide healthcare professionals with real-time access to medical information
The company's AI-powered chatbot can answer questions about medical topics by retrieving information from a pool of more than 35 million journal articles
OpenEvidence is competing with UpToDate, a widely used database owned by Wolters Kluwer, by offering an interactive and more comprehensive approach to medical information retrieval
The startup has raised $32 million in funding and is currently in early access for licensed medical professionals.
ProblemHealthcare
"Doctors need to stay up-to-date on the latest medical research, but with thousands of new studies published daily, it's impossible to keep up."
Solution
"OpenEvidence is an AI-powered tool that gives doctors instant access to the latest scientific research. It can answer specific medical questions and provide citations, saving doctors time and helping them provide better care."